Navigation Links
Shire plc: IFRS Results for the Year Ending December 31, 2007
Date:3/25/2008

1,796.5 +36

_________ _________ ________

Product sales

Year to December 31,

Product sales US prescription

2007 2006 growth growth

US$M US$M % %

______________ __________ ______________ ________

Specialty

Pharmaceuticals

ADHD

ADDERALL XR 1,030.9 863.6 +19 +3

VYVANSE 76.5 - N/A N/A

DAYTRANA 64.2 25.1 +156 +166

ADDERALL - 23.6 N/A N/A

GI

PENTASA 176.4 137.8 +28 +3

LIALDA/MEZAVANT 50.5 - N/A N/A

RENAL

FOSRENOL 102.2 44.8 +128 +5

DYNEPO 14.2 - N/A N/A

Other

therapeutic

areas

CALCICHEW 54.2 45.5 +19 N/A

CARBATROL 72.3 68.3 +6 -5

XAGRID 66.8 53.3 +25 N/A

REMINYL/REMINYL XL 31.2 21.5 +45 N/A

Other 105.1 111.0 -5

_____________ __________ ______________

1,844.5 1,394.5 +32

_____________ __________ ______________

Human Genetic

Therapies

REPLAGAL 143.9 117.7 +22 N/A

ELAPRASE 181.8 23.6 +670 N/A

_____________ __________ _____________

325.7 141.3 +131

_____________ __________ _____________

Total 2
'/>"/>

SOURCE Shire plc
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related biology technology :

1. Shire plc: Excellent Performance Across All Areas of the Business and Accelerating New Product Sales Drive Revenue Growth of 36%
2. Shire plc: Correction Re Website
3. Shires ELAPRASE(R) (idursulfase) Approved in Mexico for Treatment of Hunter Syndrome
4. Shire Engages Palio
5. Texas Boy Receives Wheelchair From New Hampshire Couples Recently Deceased Granddaughter
6. FDA Approves Additional Dosage Strengths of Shires ADHD Treatment VYVANSE(TM) (lisdexamfetamine dimesylate) Which May Help Physicians Tailor Treatment for Individual Patients
7. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
8. Alba Therapeutics Corporation and Shire plc Enter Into $325 Million ex-US, ex-Japan Licensing Agreement to Develop and Commercialize AT-1001
9. Shire plc: Board Changes
10. David Mott Appointed Non Executive Director at Shire
11. Correction: Shire plc: Third Quarter 2007 results date notification November 1, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... , Aug. 27, 2015 /PRNewswire/ - Portage ... Exchange: PBT.U), and Biohaven Pharmaceutical Holding Company Limited ... a Phase I study of BHV-0223, a glutamate ... (IND) regarding BHV-0223 and recently obtained clearance from ... proceed with human testing. Portage holds 54% equity ...
(Date:8/27/2015)... Aug. 27, 2015 HUYA Bioscience International (HUYA) today ... the Japan Society of HTLV-1, held this week at ... purpose of the Society is to promote research on ... of medical technology and research related to these fields ... "HUYA is proud to support this prestigious conference," ...
(Date:8/27/2015)... 27, 2015 In response to recent ... and The US Postal Service to no longer ... ,select agents, by the CDC, Marken reaffirmed today ... sensitive shipments. Marken uses its flexible ... and certified personnel to ensure the safe and ...
(Date:8/26/2015)... 26, 2015  Roka Bioscience, Inc. (NASDAQ: ROKA ... testing solutions for the detection of foodborne pathogens, today ... the Sidoti & Company Emerging Growth Conference on September ... at the New York Marriott Marquis. ... through the investor relations section of Roka Bioscience,s website ...
Breaking Biology Technology:Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 2Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 3Portage's Biohaven doses first human subject in Phase 1 trial with lead drug candidate BHV-0223 4HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 2HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 3HUYA Bioscience International Sponsors Japan Society Of HTLV-1 Annual Meeting 4Marken Ensures Safe Transportation Of Select Agents And Toxins 2
... AMSTERDAM, November 11 Amsterdam Molecular,Therapeutics (Euronext: AMT), a ... that it has successfully treated Duchenne muscular dystrophy,(DMD) in ... proof of,concept studies were performed in collaboration with the ... Italy) and demonstrated,effectiveness in the heart as well as ...
... 10 DATATRAK International, Inc. (OTCQX: DATA), a technology ... the clinical trials industry, today announced the award of ... Symbio, LLC. A CRO specializing in dermatology, Symbio ... data entry and EDC. In an effort to ...
... Nov. 10 Curemark, LLC, a drug research and ... one of 32 biotech companies headed by women selected ... held recently in Silicon Valley, Madison, Wisconsin, and New ... U.S. and abroad applied to participate. , "The opportunity ...
Cached Biology Technology:AMT Successful in Preclinical Treatment of DMD 2AMT Successful in Preclinical Treatment of DMD 3DATATRAK Signs New Client for Rescue Study 2DATATRAK Signs New Client for Rescue Study 3DATATRAK Signs New Client for Rescue Study 4Curemark Presents at Springboard Enterprises Life Sciences Forum 2
(Date:8/5/2015)... The biosensors market is proving highly attractive ... newer sectors, and development of devices resulting in higher ... seen the entry of multiple participants each year with ... (Photo - http://photos.prnewswire.com/prnh/20150805/255570 ) Recent ... Global Biosensors Market ( http://www.frost.com/nee9 ), finds that ...
(Date:8/3/2015)... Calif. , Aug. 3, 2015 Synaptics, ... human interface solutions, today announced that members of the ... at the Pacific Crest Global Technology Leadership Forum on ... The conference will be held at the Sonnenalp Resort ... The presentation may include forward-looking information. An audio ...
(Date:7/31/2015)... julho de 2015 A 10 a. ... realizada pela BGI de 22-25 de outubro de 2015, em ... A conferência está celebrando seu 10 o. aniversário este ... tornou uma das reuniões mais influentes do mundo no ... dinâmicos, entusiastas e prazerosos. A ICG-10 ...
Breaking Biology News(10 mins):Innovative Biosensors Incite Use in Non-Traditional Applications 2Innovative Biosensors Incite Use in Non-Traditional Applications 3Innovative Biosensors Incite Use in Non-Traditional Applications 4A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3
... Technological University (NTU) and Rice University (Rice), a ... jointly establish the Institute of Sustainable and Applied ... bi-national institute will create new science and engineer ... other radical new information technologies that are more ...
... the ability of ecosystems to perform vital servicessuch ... the nation,s largest organization of ecological scientists. In ... America (ESA) outlines strategies that focus on restoring ... adapt to climate change. "Decision-makers cannot overlook ...
... new study from plant biologists at UC Davis shows that ... the membranes of chloroplasts, just as they do for other ... January issue of the journal The Plant Cell . ... cell is to move things across membranes, both in and ...
Cached Biology News:NTU, Rice establish infodynamics institute 2NTU, Rice establish infodynamics institute 3Managing ecosystems in a changing climate 2Managing ecosystems in a changing climate 3Green plant transport mystery solved 2
Component in MasterPure™ Purification Kits...
...
Tris-EDTA Buffer Solution, 1X, pH 8.0, sterile...
Human Cell Line Slides...
Biology Products: